Related Experiment Video
Updated: Feb 22, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C in a new therapeutic era: Recontextualising the lived experience
David Whiteley1,2,3, Anne Whittaker2,3, Lawrie Elliott4
1Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
Insights
New interferon-free treatments for hepatitis C have emerged, but patient understanding of the virus remains unchanged. This can hinder engagement with new therapies and impact public health outcomes.
Area of Science:
- Hepatology
- Public Health
- Qualitative Research
Background:
- Hepatitis C poses a significant global health challenge, with historical treatments being poorly effective and demanding.
- Recent advancements have introduced more tolerable and effective interferon-free therapies, particularly in high-income countries.
Purpose of the Study:
- To explore the lived experiences of adults with hepatitis C in the context of new interferon-free treatments.
- To understand how evolving treatment landscapes influence patients' perceptions and understanding of hepatitis C.
Main Methods:
- A qualitative study employing social phenomenological theory.
- Semi-structured interviews were conducted with 20 adults diagnosed with hepatitis C in Scotland.
Main Results:
- Thematic analysis revealed three key themes: "Positioning hepatitis C" (sociocultural, medical, and economic contexts), "Beyond a physical burden" (emotional impact), and "a new uncertainty" (cautious reception of new treatments).
- Participant narratives indicated that "lay" understandings of hepatitis C have not significantly shifted despite treatment advancements.
Conclusions:
- The new era of hepatitis C treatment has had limited impact on deeply ingrained patient perceptions of the illness.
- Unaltered lay understandings of hepatitis C may present barriers to fully realizing the potential of new therapies.
- Patient perceptions significantly influence engagement with care; challenges remain for healthcare providers in integrating patients into new therapeutic pathways.
Aims And Objectives:
To explore the experience of adults living with hepatitis C in a new era of interferon-free treatment.
Background:
Hepatitis C is a leading cause of morbidity and mortality worldwide, posing a significant challenge to global public health. Historically, the treatment of hepatitis C was poorly efficacious and highly demanding; however, more effective and tolerable therapies have become available in high-income nations in recent years. This is the first study to explore how these significant developments in the treatment of hepatitis C may have influenced the experience of those living with the virus, and their understanding of the disease.
Design:
A qualitative study underpinned by social phenomenological theory.
Methods:
Data were generated through semi-structured interviews with a purposive sample of 20 hepatitis C positive adults living in a large city in Scotland.
Results:
Thematic analysis identified three overriding themes. "Positioning hepatitis C" illustrated how the disease was understood within wider sociocultural, medical and politico-economic contexts. "Beyond a physical burden" emphasised the emotional aspect of infection, and "a new uncertainty" revealed participants' cautious response to the advances in hepatitis C therapy.
Conclusions:
Interthematic discourse portrayed the new era of hepatitis C treatment as holding little sway over constructions of the illness, as narratives resonated with previous studies. Such unmoving "lay" understandings of hepatitis C may pose potential barriers to the new therapeutic era from reaching its full potential.
Relevance To Clinical Practice:
How people living with the virus perceive and understand hepatitis C can have an adverse impact on their engagement with care and treatment. Whilst global medical discourse eulogises the arrival of a new era of therapy, there remain significant challenges for nurses engaging those with hepatitis C in therapeutic pathways.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...